All trading involves risk. Losses can exceed deposits.

Levels to watch: FTSE 100, DAX and S&P 500

UK and US markets continue to leave their European cousins far behind.

All trading involves risk. Losses can exceed deposits.

FTSE 100 climbs to a new high

The grind higher continues for FTSE 100, with no sign that the sellers can assert control for any meaningful length of time.

The potential areas of short-term support are marked at 7732 and then 7705.

DAX flounders as euro strengthens

Euro strength continues to hobble European markets including DAX; a worrying holdover from 2017.

However, the price continues to defend 13,211, so if this keeps holding the chances of a return to 13,400, and then towards 13,600, increase. Further support is possible around 13,150, and then 13,095. 

S&P 500 surges to new records

Dip buyers of S&P 500 this week, who took the oversold stochastics as a buying opportunity, have done well.

The rally shows no sign of stopping, despite a plethora of signs indicating overextended conditions. Possible support is standing by at 2759, 2737 and then 2729.

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.